Brief: Thorne Healthtech's Onedraw Device Used In Department Of Defense's Cancer Moonshot 2.0 Project, Prometheus, As Part Of President Biden Initiative
17/11/2022 12:44
Nov 17 (Reuters) - Thorne Healthtech Inc THRN.O :
* THORNE HEALTHTECH'S ONEDRAW DEVICE USED IN DEPARTMENT OF
DEFENSE'S CANCER MOONSHOT 2.0 PROJECT, PROMETHEUS, AS PART OF
PRESIDENT BIDEN INITIATIVE
Source text for Eikon: ID:nPn2sTMV6a
Further company coverage: THRN.O
Recent news on Thorne HealthTech
See all newsBrief: L Catterton And Thorne Healthtech, Inc. Announce Expiration Of Tender Offer
Brief: L Catterton And Thorne Healthtech Announce Expiration Of Tender Offer
Brief: Thorne Healthtech Received Notice Of Delisting From Nasdaq
Brief: Kirin Holdings To Sell All Of 29.1% Stake It Owns In Thorne Healthtech For About 23 Billion Yen - Nikkei
U.S. RESEARCH ROUNDUP- Celsius Holdings, RPT Realty, Thorne Healthtech